MX9601424A - Indenoilguanidinas sustituidas antiarritmicas y cardioprotectoras. - Google Patents
Indenoilguanidinas sustituidas antiarritmicas y cardioprotectoras.Info
- Publication number
- MX9601424A MX9601424A MX9601424A MX9601424A MX9601424A MX 9601424 A MX9601424 A MX 9601424A MX 9601424 A MX9601424 A MX 9601424A MX 9601424 A MX9601424 A MX 9601424A MX 9601424 A MX9601424 A MX 9601424A
- Authority
- MX
- Mexico
- Prior art keywords
- indenoylguanidines
- arrhythmic
- compounds
- formula
- cardioprotective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Optical Record Carriers And Manufacture Thereof (AREA)
Abstract
Se describen indenoilguanididnas de formula I, el procedimiento para su preparacion, su uso como medicamentos, medicamentos que las contienen, su uso como agentes de diagnostico y medicamentos que los contienen. Los compuestos I son utiles para tratar arritmias cardíacas. Además, estos compuestos son utiles como agentes cardioprotectores en mamíferos, que comprende administrar a dicho mamífero el compuesto de formula I con las propiedades anteriores, en combinacion con un excipiente farmacéuticamente aceptado.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95105724 | 1995-04-18 | ||
EP95105724.9 | 1995-04-18 | ||
US08/633,223 US5733934A (en) | 1995-04-18 | 1996-04-16 | Antiarrythmic and cardioprotective substituted indenoylguanidines |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9601424A true MX9601424A (es) | 1997-07-31 |
MXPA96001424A MXPA96001424A (es) | 1997-12-01 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
GR3031540T3 (en) | 2000-01-31 |
IL117927A (en) | 2001-12-23 |
EP0738712B1 (en) | 1999-08-18 |
CN1061648C (zh) | 2001-02-07 |
CZ109696A3 (en) | 1996-11-13 |
RU2182902C2 (ru) | 2002-05-27 |
CN1140164A (zh) | 1997-01-15 |
SI0738712T1 (en) | 1999-12-31 |
DK0738712T3 (da) | 2000-03-06 |
US5733934A (en) | 1998-03-31 |
ES2135811T3 (es) | 1999-11-01 |
SK48396A3 (en) | 1996-12-04 |
EP0738712A1 (en) | 1996-10-23 |
HUP9600998A3 (en) | 1997-11-28 |
SK282011B6 (sk) | 2001-10-08 |
BR9601989A (pt) | 1998-04-07 |
NO305655B1 (no) | 1999-07-05 |
IL117927A0 (en) | 1996-08-04 |
ATE183498T1 (de) | 1999-09-15 |
HU9600998D0 (en) | 1996-06-28 |
HUP9600998A2 (en) | 1997-01-28 |
DE69603771T2 (de) | 2000-09-07 |
NZ286380A (en) | 1997-09-22 |
PL182566B1 (pl) | 2002-01-31 |
AU5067696A (en) | 1996-10-31 |
CZ291538B6 (cs) | 2003-03-12 |
NO961521L (no) | 1996-10-21 |
AU706055B2 (en) | 1999-06-10 |
ZA963046B (en) | 1996-10-22 |
NO961521D0 (no) | 1996-04-17 |
TR199600316A1 (tr) | 1997-03-21 |
DE69603771D1 (de) | 1999-09-23 |
JPH08291131A (ja) | 1996-11-05 |
CA2174406A1 (en) | 1996-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT47217A (en) | Process for producing pharmaceutical compositions containing indol derivatives as active components | |
ZA941542B (en) | Heterocyclic compounds their use and preparation | |
CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
ZA916579B (en) | Heterocyclic compounds and their preparation and use | |
ZA916580B (en) | Heterocyclic compounds and their preparation and use | |
BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
ZA863382B (en) | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs | |
ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
UA19156A (uk) | Спосіб одержаhhя амідіhів або їх фармацевтичhо прийhятhих солей | |
HU9600998D0 (en) | Antiarrhythmic and cardioprotective substituted indenoylguanidines | |
HUT42102A (en) | Process for preparing peptides with pharmaceutical activity | |
UA41329C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії | |
GR3006606T3 (es) | ||
MX9605538A (es) | Benzoil-guanidinas sustituidas con sulfonilamino, procedimiento para su preparacion, su empleo como medicamento o para diagnostico, asi como el medicamento que las contiene. | |
GR3017434T3 (en) | Azacyclic or azabicyclic compounds, their preparation and use. | |
MX9606397A (es) | Cromanilsulfonil(tio)ureas sustituidas, procedimientos para prepararlas, y su utilizacion en preparados farmaceuticos, asi como preparados farmaceuticos que las contienen. | |
CA2157579A1 (en) | Heterocyclic compounds, their use and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |